logo-loader
viewInMed Pharmaceuticals, Inc.

InMed CEO says 'tremendous potential' for its cannabinoid-based therapy to treat glaucoma

InMed Pharmaceuticals Inc (CSE:IN) (OTCMKTS:IMLFF) CEO Eric Adams sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. Based in Vancouver, British Columbia, the pre-clinical stage biopharmaceutical company specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.

Quick facts: InMed Pharmaceuticals, Inc.

Price: 0.33 CAD

TSX:IN
Market: TSX
Market Cap: $56.85 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Silver Range Resources is a prospect generator with...

Silver Range Resources (CVE: SNG) President and CEO Mike Power sat down with Steve Darling from Proactive Vancouver to discuss the company with projects in Nevada, Northwest Territories and Nunavut. 45 in total. Power telling Proactive about some of their most advanced assets or those being...

2 hours, 17 minutes ago

2 min read